Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: The influence of the intestinal microflora to the efficacy of Rosuvastatin

Fig. 3

The diversity of intestinal microflora analysis at different time points after Rosuvastatin administration. a and b, the photograph (a) and quantification (b) of the diversity of the intestinal microflora of rats from Ceftriaxone-treated Group Antibiotic+Statin (lane 1–4), Group Statin (lane 5–8) and Control Group Water (lane 9–12) using PCR-DGGE analysis 2 weeks after Rosuvastatin treatment. C and D, the photograph (c) and quantification (d) of the diversity of the intestinal microflora of rats from Ceftriaxone-treated Group Antibiotic+Statin (lane 1–4), Group Statin (lane 5–8) and Control Group Water (lane 9–12) using PCR-DGGE analysis 4 weeks after Rosuvastatin treatment. The comparisons were performed using one-way ANOVA with Tukey’s multiple comparisons test. The data were presented as mean ± sem. ***, p < 0.001

Back to article page